TIGC Symposium 2005

What's New in Antithrombotic Therapy? - Cerebrovascular Disease, Coronary Artery Disease and Peripheral Arterial Disease
Toronto Convention Centre, Toronto, 05 November 2005

Learning Objectives:

• Platelets: Gaining a greater understanding of the role of platelet function and the clinical impact of platelet dysfunction
• Atherothrombosis: To discuss and review the latest advances in Antithrombotic therapy for acute and long term treatment of patients with cerebrovascular, cardiovascular and peripheral arterial disease (including CCS-PAD consensus)
• TIGC: Understand how the Thrombosis Interest Group of Canada can assist physicians in their clinical practice

ePresence PC version (click on links below to view archived presentations)

• Dr. Alexander G.G. Turpie - Welcome & Overview
• Dr. Andre Roussin - The Thrombosis Interest Group of Canada: Who are we
• Dr John Eikleboom - Understanding the Role of Platelet Function
• Dr.Shamir Mehta - ACS and the Long Term Management of the ACS Patient
• Dr. Michael Sharma - Rapid Diagnosis, Short and Long Term Management
• Dr. Sonia Anand - Peripheral Arterial Disease: Guideline Update
• Q&A Session

NOTE: must be viewed using Microsoft Internet Explorer with 1024x768 monitor resolution, and Windows Media Player 9 or higher